|
000
| 01042nam##2200253za#4500 |
|---|
| 001 | 9.693873 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624233848 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2010||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-897463-72-7 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH174-18/2010E-PDF |
|---|
| 110 | 1 |aCanada.|bHealth Council of Canada. |
|---|
| 245 | 10|aGeneric drug pricing and access in Canada : |h[electronic resource]|bwhat are the implications? / |cby SECOR Consulting. |
|---|
| 260 | |aToronto - Ontario : |bHealth Council of Canada |cJune 2010. |
|---|
| 300 | |a48p.|bcoloured figs., organization chart, references, tables |
|---|
| 500 | |a"A Commissioned Discussion Paper by SECOR Consulting" |
|---|
| 590 | |a10-39|b2010-10-01 |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 690 | 07|aPrices|2gcpds |
|---|
| 775 | 08|tPrix et accessibilité des médicaments génériques au Canada : |w(CaOODSP)9.638071 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s1085 KB|uhttps://publications.gc.ca/collections/collection_2010/ccs-hcc/H174-18-2010-eng.pdf |
|---|